Home›Companies›Biotech & Pharma›Paulex Bio

Paulex Bio Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 18, 2025·Suggest an edit

About Paulex Bio

Paulex Bio is a private company based in LA Jolla, California, incorporated in 2023 in Delaware. It has reported $18,516,040 raised in one offering on Form D since December 2025. Its chief executive is Sanjuan Miguel.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 21, 2025Dec 18, 2025$18,516,040of $22.5M target163$113KEquity, OptionsRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Paulex Bio's Form D filed Dec 18, 2025.

ER
Edgardo Rayo
Director
MH
Francisco Leon
Francisco Leon
Director
Also a director at Lapix Therapeutics and a founder and CEO, director at Tolerance Bio.
SM
Sanjuan Miguel
Chief Executive Officer and director

Sources

  1. SECPaulex Bio Inc. filing history